Chinese Medical Journal.2001;114(9):986-987.
Chinese Medical Journal
1966 to Present ISSN: 0366-6999
Sort by
Format:
Per page:
Chinese Medical Journal.2001;114(9):986-987.
Current research in management of hematological diseases with poor prognosis.
Chinese Medical Journal.2001;114(7):675-675.
A Rare Case of Persistent Primitive Trigeminal Artery with Multiple Anomalies of Cerebral Vessels.
Chinese Medical Journal.2016;129(24):3008-3009. doi:10.4103/0366-6999.195471
Only Self-control, Concerted Efforts Can Settle Rising Obesity in Adolescents.
Chinese Medical Journal.2016;129(24):3007-3007. doi:10.4103/0366-6999.195477
A New Physical Examination Technique for Evaluating Valgus Knee Deformity: Swing Test.
Chinese Medical Journal.2016;129(24):3004-3006. doi:10.4103/0366-6999.195465
Neurodegeneration in Diabetic Retinopathy: Current Concepts and Therapeutic Implications.
Chinese Medical Journal.2016;129(24):3001-3003. doi:10.4103/0366-6999.195478
Chinese Medical Journal.2016;129(24):2998-3000. doi:10.4103/0366-6999.195475
Chinese Medical Journal.2016;129(24):2991-2997. doi:10.4103/0366-6999.195467
OBJECTIVEThe arrival of precision medicine plan brings new opportunities and challenges for patients undergoing precision diagnosis and treatment of malignant tumors. With the development of medical imaging, information on different modality imaging can be integrated and comprehensively analyzed by imaging fusion system. This review aimed to update the application of multimodality imaging fusion technology in the precise diagnosis and treatment of malignant tumors under the precision medicine plan. We introduced several multimodality imaging fusion technologies and their application to the diagnosis and treatment of malignant tumors in clinical practice.
DATE SOURCESThe data cited in this review were obtained mainly from the PubMed database from 1996 to 2016, using the keywords of "precision medicine", "fusion imaging", "multimodality", and "tumor diagnosis and treatment".
STUDY SELECTIONOriginal articles, clinical practice, reviews, and other relevant literatures published in English were reviewed. Papers focusing on precision medicine, fusion imaging, multimodality, and tumor diagnosis and treatment were selected. Duplicated papers were excluded.
RESULTSMultimodality imaging fusion technology plays an important role in tumor diagnosis and treatment under the precision medicine plan, such as accurate location, qualitative diagnosis, tumor staging, treatment plan design, and real-time intraoperative monitoring. Multimodality imaging fusion systems could provide more imaging information of tumors from different dimensions and angles, thereby offing strong technical support for the implementation of precision oncology.
CONCLUSIONUnder the precision medicine plan, personalized treatment of tumors is a distinct possibility. We believe that multimodality imaging fusion technology will find an increasingly wide application in clinical practice.
Chinese Medical Journal.2016;129(24):2983-2990. doi:10.4103/0366-6999.195470
BACKGROUNDControversial results about the therapeutic value of radiofrequency ablation (RFA) and liver resection (LR) in the treatment of colorectal cancer liver metastasis (CRCLM) have been reported. Thus, we performed the present meta-analysis to summarize the related clinical evidences.
METHODSA systematic literature search was conducted using PubMed (Medline), EMBASE, Cochrane Library, and Web of Science, for all years up to April 2016. Pooled analyses of the overall survival (OS), progression-free survival (PFS), and morbidity rates were performed.
RESULTSA total of 14 studies were finally enrolled in the meta-analysis. Patients treated by LR gained a longer OS and PFS than those of patients treated by RFA. Patients in the RFA group had lower morbidity rates than those of patients in the LR group. Publication bias analysis revealed that there was no significant publication bias in the meta-analysis.
CONCLUSIONSPatients with CRCLM gained much more survival benefits from LR than that from RFA. RFA rendered lower rates of morbidities. More well-designed randomized controlled trails comparing the therapeutic value of LR and RFA are warranted.
Chinese Medical Journal.2016;129(24):2974-2982. doi:10.4103/0366-6999.195464
BACKGROUNDThe effectiveness of neoadjuvant chemoradiotherapy (NCRT) treatment for patients with esophageal carcinoma (EC) remains controversial. The aim of this study was to compare the effect of NCRT followed by surgery (NCRTS) with surgery alone (SA) for EC.
METHODSThe PubMed, EMBASE, and the Cochrane Library databases were electronically searched up to August 2015 for all the published studies that investigated EC patients receiving either NCRTS or SA, and the reference lists were also manually examined for the eligible studies. The risk ratio (RR) with 95% confidence intervals (CI s) as effective size was determined to assess the 1-, 3-, 5-year survival rates (SRs), postoperative morbidity, and postoperative mortality. Heterogeneity was determined using the Q-test. The Begg's test and Egger's test were used for assessing any potential publication bias.
RESULTSOf 1120 identified studies, 16 eligible studies were included in this analysis (involving 2549 patients). Overall, the pooled results suggested that NCRTS was associated with significantly improved 1-year (RR: 1.07, 95% CI: 1.02-1.13), 3-year (RR: 1.26, 95% CI: 1.14-1.39), and 5-year (RR: 1.36, 95% CI: 1.18-1.56) SRs. However, the results also indicated that NCRTS had no or little effect on postoperative morbidity (RR: 0.93, 95% CI: 0.82-1.05) and postoperative mortality (RR: 1.17, 95% CI: 0.56-2.44).
CONCLUSIONSCompared with SA, NCRTS can increase 1-, 3-, and 5-year SRs in patients with EC.
Country
China
Publisher
中华医学会
ElectronicLinks
https://journals.lww.com/cmj/pages/default.aspxEditor-in-chief
cmjsubs@cmj.org
Abbreviation
Chinese Medical Journal
Vernacular Journal Title
中华医学杂志(英文版)
ISSN
0366-6999
EISSN
Year Approved
2007
Current Indexing Status
Currently Indexed
Start Year
1966
Description
历史沿革【现用刊名:Chinese Medical Journal;曾用刊名:中华医学杂志(英文版);创刊时间:1966】,该刊被以下数据库收录【CA 化学文摘(美)(2009);SCI 科学引文索引(美)(2009);CBST 科学技术文献速报(日)(2009);Pж(AJ) 文摘杂志(俄)(2009)】,期刊荣誉【中科双高期刊;第二届全国优秀科技期刊】。